teva ceo Articles and latest stories

US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute

Israel's Teva Pharmaceuticals and GlaxoSmithKline (GSK) have been disputing over this patent lawsuit since 2014.

By REUTERS

Hot Opinion

Threat of Iran's proxies isn't gone, Israeli gov't cannot lose focus

By JPOST EDITORIAL

Editor's Notes: No more status-quo, we need a solution to the Israeli-Palestinian conflict

By ZVIKA KLEIN

KAN are not the enemy: Ministers acting against Israel’s democratic character

By YAAKOV KATZ

West's leadership crisis is different in Israel

By AMOTZ ASA-EL

My Word: Wide awake in a war

By LIAT COLLINS

The Jerusalem Post Customer Service Center can be contacted with any questions or requests:
Telephone: *2421 * Extension 4 Jerusalem Post or 03-7619056 Fax: 03-5613699 E-mail: subs@jpost.com
The center is staffed and provides answers on Sundays through Thursdays between 07:00 AM and 14:00 PM and Fridays only handles distribution requests between 7:00 AM and 12:30 PM
For international customers: The center is staffed and provides answers on Sundays through Thursdays between 7AM and 14PM Israel time Toll Free number 1-800-448-9291 Telephone +972-3-761-9056 Fax: 972-3-561-3699 E-mail: subs@jpost.com

teva ceo

US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute

Operation 'Bashan Arrow': IDF destroys over 350 Syrian Military targets

Syria can help Israel 'completely destroy armies without war,' expert says

Russia warns the United States of the risks of World War Three

IDF troops reach Damascus’ doorstep, uncover Syrian military weakness

Why are Iran and Turkey moving to condemn Israel’s role in Syria?

Threat of Iran's proxies isn't gone, Israeli gov't cannot lose focus

Editor's Notes: No more status-quo, we need a solution to the Israeli-Palestinian conflict

KAN are not the enemy: Ministers acting against Israel’s democratic character

West's leadership crisis is different in Israel

My Word: Wide awake in a war